Specialization Inundation

Needed: Molecular biologist. Requirements: CHO cell biologist with bioreactor experience of greater than 200 liters. Recruiters provide an antidote to life scientists who barrage biotechnology companies with resumes for every job posting: Niche hiring. By helping companies filter for a particular forte, recruiters quickly identify exactly what their clients want, such as a CHO cell biologist with bioreactor experience of greater than 200 liters. For a position like this, most scientists with o

Written byJennifer Fisher Wilson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

"Employers follow this path because the nature of the product development in biotechnology demands it," says David G. Jensen, principal consultant for Search Masters International, based in Downers Grove, Ill. "But employers have complicated niche hiring themselves by filling jobs only with extremely specialized people where there may have existed the option to hire those who could quickly and efficiently be brought into the system."

Not only does niche hiring shut out good people from jobs, but it also can drain creativity, according to Leo Kim, a consultant and former executive vice president and chief technical officer for Mycogen, a biotechnology company in San Diego, Calif. Managers could build a better workforce by hiring creative, critical thinkers as well as good implementers, and giving people a chance to broaden their experience, rather than simply recycle a niche skill, Kim says. "Creativity should go on at the bench, often when the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies